LFMD

LifeMD, Inc.

$1.66

-7.02%
SectorHealthcareIndustryHealth Information ServicesCountryUnited States

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss.

Source: Yahoo Finance
AI summary

Price & performance

1M-19.4%
3M-36.3%
YTD-33.5%
1Y-62.1%
52-week range—
Beta1.69
Full chart and returns against a benchmark

Q-Score

46/ 100

Quality against peers; 50 is the peer median.

Growth47
Risk43
Performance38
Valuation57
Profitability68
Leverage38
Sentiment29
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$194.1M+25.3%
Net income$14.4M
Net margin7.4%+21.2 pts
Historical fundamentals

Red flags in filings

2active red flags
Material weakness in controlsMar 10, 2026
Auditor changeAug 21, 2025
Filings, findings and the timeline

Revenue exposure

0%of revenue from outside the US
United States100%
Regions, segments, customers and suppliers

Valuation

LFMDIndustryP/E397.3167.40P/S0.424.25EV/EBITDA—44.97P/B10.026.14PEG—0.25
Dividend yield3.89%
Every valuation metric

Earnings

Nov 12next report, after the close
EPS estimate$-0.01
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate